title: "Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections".
authors.affiliation: Department/Institution, Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, University hospital Dubrava, University of Zagreb School of Medicine, Avenija Gojka Šuška 6, Zagreb, Croatia.
authors.forename: Silva
authors.initials: S
authors.lastname: Pukšić
authors.forename: Joško
authors.initials: J
authors.lastname: Mitrović
authors.forename: Jadranka
authors.initials: J
authors.lastname: Morović-Vergles
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects; D016903:Drug Monitoring / Q000379:methods; D004351:Drug Resistance; D005258:Felty Syndrome / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007239:Infections / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D007958:Leukocyte Count / Q000379:methods; D008875:Middle Aged; D012008:Recurrence; D000069283:Rituximab / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069283:Rituximab